Multi-event July 2019 FDA Recall Nitrofurantoin Monohydrate/ Macrocrystalline by Alvogen, Inc

This Multi-event Class II drug recall was voluntarily initiated by Alvogen, Inc on July 24, 2019 for the product Nitrofurantoin Monohydrate/ Macrocrystalline. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed in Natonwide, PR and the recall is currently terminated.

Reported Recall Events

Recall Number: D-1723-2019

Reason for Recall
Failed dissolution specifications
Initiated
07-24-2019
Reported
08-21-2019
Quantity
4272 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Macrobid Urinary Tract Anitbacterial, 100 mg, 100-count bottle, Rx Only, Mfg. by: Norwich Pharmaceuticals, Inc. Norwich, NY 13815 USA Dist. by: Almatica Pharma, Inc. Pine Brook, NJ 07058 USA, NDC 52427-285-01

Batch or Lot Expiration Information

Lot# 472990, Exp 03/2020

Affected Packages Involved in this Recall

Recall Number: D-1722-2019

Reason for Recall
Failed dissolution specifications
Initiated
07-24-2019
Reported
08-21-2019
Quantity
2784 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nitrofurantoin Monohydrate/Macrycrystals Capsules, 100 mg, 100-count bottle, Rx Only, Distributed by: Alvogen, Inc. Pine Brook, NY 07058 USA, NDC 47781-303-01

Batch or Lot Expiration Information

Lot# 471976, Exp 03/2020

Affected Packages Involved in this Recall